To understand why a 10-minute test is a "breakthrough," we first have to understand the invisible enemy it fights. Fentanyl exposure refers to the ingestion, inhalation, or absorption of fentanyl—a synthetic opioid that is 50 to 100 times more potent than morphine.
While fentanyl is a legitimate medical tool for severe pain, it has become the primary driver of the overdose epidemic due to its presence in illicitly manufactured drugs.
Until now, many hospitals relied on comprehensive laboratory screenings that could take hours or even days to return a definitive result. In an ER setting, doctors often had to treat patients based on "best guesses."
The Labcorp Fentanyl Urine Visual Test changes the game. It is a "lateral flow immunoassay"—the same technology used in home pregnancy or COVID-19 tests. A healthcare provider simply applies a urine sample to a cassette, and within 10 minutes, a visual line appears to indicate the presence of the drug.
One of the most impressive features of this test is that it doesn't just look for fentanyl itself; it looks for Norfentanyl.
This is the first FDA-cleared rapid fentanyl test of its kind manufactured in the United States. In recent years, global supply chain issues have occasionally made it difficult for hospitals to get the diagnostic tools they need. By producing this test domestically, Labcorp ensures a more stable and reliable supply for American emergency rooms, clinics, and hospitals.
Imagine an emergency room physician treating an unconscious patient. They see signs of an overdose, but they aren't sure if it’s opioids, a different medication, or a different medical emergency entirely (like a stroke).
With this 10-minute test, the "guesswork" is largely removed. Doctors can confirm fentanyl exposure almost immediately and proceed with life-saving treatments with total confidence. It provides peace of mind for families and a clear path forward for medical teams.